A Rapid and Effective Tool for Monitoring Monoclonal Antibody Production
Poster Aug 13, 2014
B. Bhullar, Ph.D., Carlina Hui, B.Sc., M. Hariharan, M.Sc., J. Hewitt, B.Sc , and N. Vats, Ph.D.
IVD manufacturers must establish QC systems to assure that the product received is suitable for use. As an alternative to laborious time consuming conventional methods such as ELISA or dot immunobinding, we examined the effectiveness and utility of rapid point-of-use immuoanalytical tools created with MedMira's MiriadTM RVF Toolkit to quickly assess the suitability of hybridoma bioreactor supernatants.
Is Oxford Nanopore Technology Ready for Clinical Diagnostics?Poster
Our objective is to validate diagnostic services using Oxford Nanopore’s Minion in the first instance and to evaluate the cost and performance compared to existing sequencing technology in areas such as tumour DNA sequencing (and circulating tumour DNA), virology, microbiology, genetics and HLA-typing.READ MORE
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluationPoster
These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.READ MORE